Summary

Europe Blood Glucose Monitoring Devices Market is valued at approximately USD 3.32 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.55% over the forecast period 2024-2032. Blood glucose monitoring devices measure the levels of glucose (sugar) in the blood. These devices are critical for managing diabetes, a condition in which blood glucose levels are unusually high. These devices help people keep their blood sugar levels within a specified range, lowering the risk of diabetes complications. Also, blood glucose monitoring devices were increasingly being integrated with digital health platforms and smartphone apps. This integration allows users to track their glucose levels, receive insights, and share data with healthcare providers remotely, leading to more personalized and proactive diabetes management.

Moreover, Europe has been witnessing a rise in diabetes prevalence, attributed to factors such as sedentary lifestyles, unhealthy dietary habits, and an aging population. As diabetes remains a significant health concern, the demand for blood glucose monitoring devices rises correspondingly. Also, there is a growing trend towards home-based healthcare, driven by factors such as the aging population, preference for remote monitoring, and efforts to reduce healthcare costs. Blood glucose monitoring devices enable patients to monitor their glucose levels conveniently at home, thereby contributing to the market growth. Additionally, favorable regulatory policies and approvals for blood glucose monitoring devices encourage innovation and market entry of new products. Regulatory bodies in Europe, such as the European Medicines Agency (EMA) and national regulatory authorities, strive to ensure the safety, efficacy, and quality of these devices, fostering market growth. However, the stringent regulatory requirements and approval processes are expected to hinder the Europe Blood Glucose Monitoring Devices Market growth during the forecast period 2024-2032.

The key countries considered for the Europe Blood Glucose Monitoring Devices market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market in terms of revenue. Growing awareness among patients about the importance of monitoring blood glucose levels regularly, coupled with increased healthcare expenditure, has led to higher adoption rates of monitoring devices in Germany. Also, government initiatives aimed at diabetes management, such as reimbursement policies for glucose monitoring devices and subsidies for diabetes care, have encouraged the use of these devices among patients. Whereas, the United Kingdom is expected to grow with the highest CAGR during the forecast period 2024-2032.

Major market player included in this report are:
Ascensia Diabetes Care Holdings AG.
Beurer GmbH
F. Hoffmann-La Roche AG
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Product
Self-monitoring Devices
Continuous Blood Glucose Monitoring Devices

By End-use
Hospitals
Home Care
Diagnostic Centers
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Europe Blood Glucose Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Blood Glucose Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Blood Glucose Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Blood Glucose Monitoring Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Blood Glucose Monitoring Devices Market Size & Forecasts by Product 2022-2032
5.1. Self-monitoring Devices
5.2. Continuous Blood Glucose Monitoring Devices
Chapter 6. Europe Blood Glucose Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Hospitals
6.2. Home Care
6.3. Diagnostic Centers
Chapter 7. Europe Blood Glucose Monitoring Devices Market Size & Forecasts by Country 2022-2032
7.1. U.K. Blood Glucose Monitoring Devices Market
7.1.1. Product breakdown size & forecasts, 2022-2032
7.1.2. End-use breakdown size & forecasts, 2022-2032
7.2. Germany Blood Glucose Monitoring Devices Market
7.3. France Blood Glucose Monitoring Devices Market
7.4. Spain Blood Glucose Monitoring Devices Market
7.5. Italy Blood Glucose Monitoring Devices Market
7.6. Rest of Europe Blood Glucose Monitoring Devices Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Ascensia Diabetes Care Holdings AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Beurer GmbH
8.3.3. F. Hoffmann-La Roche AG
8.3.4. Company 4
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes